Weiss Ratings Reiterates Sell (D-) Rating for Cardlytics (NASDAQ:CDLX)
Cardlytics (NASDAQ:CDLX – Get Free Report)‘s stock had its “sell (d-)” rating restated by equities research analysts at Weiss Ratings in a report released on Thursday,Weiss Ratings reports. Separately, Evercore ISI reduced their target price on Cardlytics from $3.00 to $2.00 and set an “in-line” rating for the company in a report on Friday, August […]
1 Nov 08:57 · The Markets Daily